Get startedLog in
    Picture of Parmax Pharma logo

    540359 — Parmax Pharma Cashflow Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual cashflow statement for Parmax Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M
    Source:ARSARSPRESS
    Standards:
    IAS
    IAS    		—
    Status:FinalFinalFinal
    Net Income/Starting Line0.461-56.6-20.9
    Depreciation
    Non-Cash Items-1.8507.71
    Other Non-Cash Items
    Changes in Working Capital-14.137.5-3.65
    Change in Accounts Receivable
    Change in Inventories
    Change in Other Assets
    Change in Other Liabilities
    Other Operating Cash Flow
    Cash from Operating Activities3.33-1.9-6.56
    Capital Expenditures-9.36-15.9-7.01
    Purchase of Fixed Assets
    Cash from Investing Activities-9.36-15.9-7.01
    Financing Cash Flow Items——-4
    Other Financing Cash Flow
    Net Issuance / Retirement of Debt
    Cash from Financing Activities-0.44214.314
    Beginning Cash Balance
    Ending Cash Balance
    Net Change in Cash-6.47-3.50.393